Siegel-Ramsay, J. E.
Sharp, S. J.
Ulack, C. J.
Chiang, K. S.
Lanza di Scalea, T.
O’Hara, S.
Carberry, K.
Strakowski, S. M.
Suarez, J.
Teisberg, E.
Wallace, S.
Almeida, J. R. C.
Article History
Received: 13 April 2022
Accepted: 22 March 2023
First Online: 20 April 2023
Declarations
:
: This study was IRB approved by the Office of Research Support and Compliance at the University of Texas at Austin. All participants gave consent to participate in the study.
: All authors have given consent for publication.
: SSM Sunovion Pharmaceuticals (Chair DSMB), Meadows Mental Health Policy Institute (Senior Fellow). No other authors have interests that might be perceived to influence the results and/or discussion reported in this paper.